Send feedback

SPTAN1 p.Asp2139=

c.6417C>T · rs140418358 · VCV378662

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 5 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0294%, afr)
Conditions
2
early-infantile DEE

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -11GERP -4
Overall
CADD6.392PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0294% African / African-American · 22/74,940 alleles
Filtering AF 0.0199% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0167%
Overall 0.00991% 160/1,614,058 alleles · ultra-rare exomes 136/1,461,842 · genomes 24/152,216 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.193% 519
African / African-Americangrpmax 0.0294% 3,406
Remaining individualsnot grpmax-eligible 0.0272% 3,676
Admixed American 0.02% 5,001
European (non-Finnish) 0.00398% 25,107
South Asian 0.00329% 30,363
East Asian 0.00223% 44,896
Finnishnot grpmax-eligible 0.00156% 64,012

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SPTAN1
Protein
p.Asp2139=
Coding
c.6417C>T
MANE Select
NM_001130438
dbSNP
rs140418358
Type
single nucleotide variant
Location
chr9:128626528 (GRCh38)
Gene constraint
LOEUF 0.222 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 77.05 · 7 PDB
Residue 2139
a UniProt-annotated variant site (in hmnd11; pathogenic; decreased protein levels in patient cells); a UniProt-annotated variant site (in devep; likely pathogenic); a UniProt-annotated variant site (in hmnd11; likely pathogenic; decreased protein levels in patient cells)
Full SPTAN1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sptan1-p-asp2139 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown